Products

medin-NC3. The new generation of non‑invasive respiratory support

"" ""

Product benefits

  • Independent from air supply thanks to high-performance turbine
  • All basic modes for non-invasive respiratory support
  • HFNC-mode and nCPAP in one device
  • Leak compensation in all CPAP modes
  • MediTRIG: Integrated trigger and apnea monitoring without additional sensor
This video describes the high flow mode of our medin-NC3. medin-NC3 is the first turbine-driven CPAP device for non-invasive respiratory support for premature infants and newborns. The high-performance turbine makes the device independent of a fixed compressed air supply.

Comprehensive non-invasive respiratory support

medin-NC3 is the first turbine-driven CPAP device for non-invasive respiratory support for premature infants and newborns. The high-performance turbine makes the device independent of a fixed compressed air supply.

The proven MediTRIG technology is used in the ApneaCPAP mode. Powerful leakage compensation offsets leakages to ensure stable and effective therapy.  

The device offers all basic modes for modern non-invasive respiratory support.

For your patients

nCPAP-Modi. Für die Kleinen

Mit dem nCPAP Modus wir der Patient mit einem kontinuierlichen positiven Atemwegsdruck unterstützt. In unseren flussgesteuerten Geräten wird der gewünschte CPAP Wert über den Atemgasfluss eingestellt. Um auftretende Leckagen z.B. über den Mund oder an der Nase auszugleichen, kann die Funktion LeakAssist aktiviert werden. Ein vorgegebener Zieldruck kann dann mit zusätzlichem Atemgasfluss angestrebt werden.

ApneaCPAP mode

Apnea is detected by MediTRIG. As a result, breaths are automatically triggered to stimulate breathing. Frequency, pressure level and breath duration can be individually adjusted.

NIPPV/BiLevel

In addition to the PEEP, breaths with fixed settings (pressure level, duration, frequency) are administered. These breaths have a higher pressure level and are not emitted in a synchronized manner.

nasal High Flow Therapy

nHFT describes the supply of heated and humidified breathing gas via a nasal cannula. The gas flow administered is thus higher than the patient’s inspiratory respiratory flow. In neonatology, a flow of more than 1 LPM is considered to be high-flow therapy, while for adults, correspondingly higher values should be applied.

MediTRIG

The MediTRIG respiratory trigger was specially developed by medin for use in premature infants and newborns. Through the combination of the pressure measurement in the Medijet® generator and the signal processing in the medin nCPAP devices, MediTRIG works without additional sensors.

MediTRIG detects central as well as obstructive apnea.

High performance turbine

The high-performance turbine makes medin-NC3 independent of a fixed compressed air supply.

medin-NC3 with HAMILTON-H900 medin-NC3 with HAMILTON-H900